Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Return on Invested Capital (2018 - 2025)

Historic Return on Invested Capital for Abvc Biopharma (ABVC) over the last 8 years, with Q3 2025 value amounting to 0.38%.

  • Abvc Biopharma's Return on Invested Capital rose 13900.0% to 0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year increase of 13900.0%. This contributed to the annual value of 2.18% for FY2024, which is 2700.0% down from last year.
  • Abvc Biopharma's Return on Invested Capital amounted to 0.38% in Q3 2025, which was up 13900.0% from 0.41% recorded in Q2 2025.
  • Abvc Biopharma's Return on Invested Capital's 5-year high stood at 0.38% during Q3 2025, with a 5-year trough of 17.52% in Q2 2023.
  • Moreover, its 5-year median value for Return on Invested Capital was 2.01% (2022), whereas its average is 2.83%.
  • Per our database at Business Quant, Abvc Biopharma's Return on Invested Capital crashed by -155400bps in 2023 and then skyrocketed by 150300bps in 2024.
  • Over the past 5 years, Abvc Biopharma's Return on Invested Capital (Quarter) stood at 1.38% in 2021, then tumbled by -104bps to 2.82% in 2022, then soared by 54bps to 1.29% in 2023, then crashed by -61bps to 2.07% in 2024, then soared by 82bps to 0.38% in 2025.
  • Its Return on Invested Capital was 0.38% in Q3 2025, compared to 0.41% in Q2 2025 and 2.07% in Q4 2024.